Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-361
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9648.026
uM
inf
0.00320
0.3886 0.5402 1.5326 0.2764
0.8808
0.7065
MDA-MB-453
TNBC
Luminal
Trastuzumab
HER2
ErbB
9723.124
uM
inf
0.00115
0.4864 0.6553 4.9994 0.2269
0.8119
0.9827
SK-BR-3
HER2amp
Luminal
Trastuzumab
HER2
ErbB
10127.123
uM
inf
inf
0.2747 0.2747 0.0000 0.4731
0.1249
0.8767
SUM102PT
TNBC
Basal B
Trastuzumab
HER2
ErbB
9777.124
uM
inf
inf
0.8331 0.8331 0.0000 0.0175
0.2896
0.6278
SUM185PE
TNBC
Luminal
Trastuzumab
HER2
ErbB
10146.124
uM
inf
inf
0.8709 0.8709 0.0000 -0.0388
0.2980
0.9296
184A1
NM
Basal
Trastuzumab
HER2
ErbB
9047.026
uM
inf
inf
0.2837 0.2837 0.0000 0.2170
0.0804
0.5972
184B5
NM
Basal
Trastuzumab
HER2
ErbB
9095.026
uM
inf
6.71320
0.7144 0.5130 4.9565 -0.0290
0.80
1.0168
CAMA-1
HR+
Luminal
Trastuzumab
HER2
ErbB
9210.026
uM
inf
inf
0.9536 0.9536 0.0000 -0.0426
-1.3374
0.9102
HCC1395
TNBC
Basal B
Trastuzumab
HER2
ErbB
9254.124
uM
inf
inf
0.8784 0.8784 0.0000 -0.0335
0.3867
0.8067
HCC1428
HR+
Luminal
Trastuzumab
HER2
ErbB
7441.102
uM
inf
inf
0.9313 0.9313 0.0000 -0.0087
0.3093
0.9144
HCC1569
HER2amp
Basal A
Trastuzumab
HER2
ErbB
7447.102
uM
inf
0.00181
0.7277 0.8106 1.1886 0.1183
0.8186
1.6467
HCC1569
HER2amp
Basal A
Trastuzumab
HER2
ErbB
9347.026
uM
inf
inf
0.7097 0.7097 0.0000 0.0656
0.4960
1.2965
AU565
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9146.122
uM
inf
0.00184
0.5003 0.6442 5.0000 0.2137
0.8848
1.3408
HCC1954
HER2amp
Basal A
Trastuzumab
HER2
ErbB
9386.026
uM
inf
inf
0.7531 0.7531 0.0000 0.0956
0.4287
1.5583
HCC38
TNBC
Basal B
Trastuzumab
HER2
ErbB
9469.026
uM
inf
inf
0.8380 0.8380 0.0000 0.0264
0.4874
1.2092
BT-474
HER2amp
Luminal
Trastuzumab
HER2
ErbB
9158.123
uM
0.01277
0.00885
-0.0100 0.0993 0.6043 0.4533
0.9046
0.8769
HBL-100
Unknown
Unknown
Pertuzumab
7429.102
mg/ml
inf
0.21142
0.9391 0.9176 0.6095 0.0085
0.7039
2.4347
MCF 10F
NM
-
Pertuzumab
7487.102
mg/ml
inf
124.94960
0.6533 -0.1750 0.2135 0.1284
0.7894
1.5273
MCF12A
NM
Basal B
Pertuzumab
7489.102
mg/ml
inf
125.00000
0.8728 0.5007 0.2455 0.0447
0.7417
2.4234
HCC1569
HER2amp
Basal A
Pertuzumab
7447.102
mg/ml
inf
124.99960
0.8861 0.6968 0.1346 0.0581
0.6369
1.6467
HCC1428
HR+
Luminal
Pertuzumab
7441.102
mg/ml
inf
inf
0.9063 0.9063 0.0000 0.0249
0.2346
0.9144
BT-20
TNBC
Basal A
Pertuzumab
5903.102
mg/ml
inf
inf
0.9324 0.9324 0.0000 -0.0074
-0.0405
1.2557
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
7813.018
uM
0.82620
0.82952
0.7195 -0.0101 4.9982 0.0073
0.6447
0.8420
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
9258.026
uM
inf
inf
0.7953 0.7953 0.0000 0.0354
0.3593
0.5632
HCC1395
TNBC
Basal B
Cetuximab
EGFR
ErbB
9254.124
uM
1.07170
0.71327
0.7439 0.4322 4.9081 -0.0186
0.7673
0.8067